Literature DB >> 11854877

Hypertonic saline (7.5%) decreases perioperative weight gain following cardiac surgery.

Kati Järvelä1, Seppo Kaukinen.   

Abstract

OBJECTIVE: To compare the effects of 7.5% hypertonic saline (HS) and 0.9% normal saline (NS) on perioperative weight gain in cardiac surgical patients.
DESIGN: Prospective, randomized study.
SETTING: University teaching hospital. PARTICIPANTS: Patients (n = 72) scheduled for elective coronary artery bypass graft surgery.
INTERVENTIONS: Patients were randomly assigned to receive either 7.5% HS (36 patients) or 0.9% NS (36 patients) as a single dose of 4 mL/kg over 30 minutes during the postoperative rewarming phase in the intensive care unit.
MEASUREMENTS AND MAIN RESULTS: Weight gain until the first postoperative morning was significantly greater in the NS group than in the HS group (1.9 plus minus 1.4 kg, median, 2.1 kg; 0.8 plus minus 1.5 kg, median, 0.8 kg; p = 0.005). One-hour diuresis after the fluid infusion was significantly greater in the HS group compared with the NS group (501 plus minus 282 mL and 237 plus minus 173 mL; p < 0.001). In the linear regression model, the 2 most important factors affecting the perioperative weight gain were the volume of fluid infused postoperatively in the intensive care unit (4,098 plus minus 916 mL in the HS group and 4,589 plus minus 1,344 mL in the NS group) and the total diuresis after surgery (3,351 plus minus 1,035 mL in the HS group and 2,942 plus minus 846 mL in the NS group).
CONCLUSIONS: HS had an intense diuretic effect, which reduced intraoperative fluid retention. This effect was confirmed by the lesser increase in body weight measured on the first postoperative morning. Copyright 2002, Elsevier Science (USA). All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11854877     DOI: 10.1053/jcan.2002.29671

Source DB:  PubMed          Journal:  J Cardiothorac Vasc Anesth        ISSN: 1053-0770            Impact factor:   2.628


  8 in total

1.  Effects of 7.5% hypertonic saline on fluid balance after radical surgery for gastrointestinal carcinoma.

Authors:  Yong-Sheng Shao; Ying-Tian Zhang; Kai-Qin Peng; Zhuo-Yong Quan
Journal:  World J Gastroenterol       Date:  2005-03-21       Impact factor: 5.742

2.  Half-molar sodium-lactate solution has a beneficial effect in patients after coronary artery bypass grafting.

Authors:  Xavier M Leverve; Cindy Boon; Tarmizi Hakim; Maizul Anwar; Erwin Siregar; Iqbal Mustafa
Journal:  Intensive Care Med       Date:  2008-06-18       Impact factor: 17.440

Review 3.  Hypertonic versus near isotonic crystalloid for fluid resuscitation in critically ill patients.

Authors:  F Bunn; I Roberts; R Tasker; E Akpa
Journal:  Cochrane Database Syst Rev       Date:  2004

4.  [Haemodynamic effects following preoperative hypervolemic haemodilution with hypertonic hyperoncotic colloid solutions in coronary artery bypass graft surgery].

Authors:  G P Molter; S Soltész; R Larsen; S Baumann-Noss; A Biedler; M Silomon
Journal:  Anaesthesist       Date:  2003-10       Impact factor: 1.041

5.  Effect of hyperosmolar sodium lactate infusion on haemodynamic status and fluid balance compared with hydroxyethyl starch 6% during the cardiac surgery.

Authors:  Cindy Elfir Boom; Poernomo Herdono; Chairil Gani Koto; Sjamsul Hadi; I Made Adi Permana
Journal:  Indian J Anaesth       Date:  2013-11

Review 6.  Intravascular volume therapy in adults: Guidelines from the Association of the Scientific Medical Societies in Germany.

Authors:  Gernot Marx; Achim W Schindler; Christoph Mosch; Joerg Albers; Michael Bauer; Irmela Gnass; Carsten Hobohm; Uwe Janssens; Stefan Kluge; Peter Kranke; Tobias Maurer; Waltraut Merz; Edmund Neugebauer; Michael Quintel; Norbert Senninger; Hans-Joachim Trampisch; Christian Waydhas; Rene Wildenauer; Kai Zacharowski; Michaela Eikermann
Journal:  Eur J Anaesthesiol       Date:  2016-07       Impact factor: 4.330

7.  Hypertonic saline for fluid resuscitation after cardiac surgery (HERACLES): study protocol for a preliminary randomised controlled clinical trial.

Authors:  Carmen A Pfortmueller; Anna S Messmer; Benjamin Hess; David Reineke; Laura Jakob; Stefanie Wenger; Jan Waskowski; Patrick Zuercher; Frederik Stoehr; Gabor Erdoes; Markus M Luedi; Stephan M Jakob; Lars Englberger; Joerg C Schefold
Journal:  Trials       Date:  2019-06-14       Impact factor: 2.279

Review 8.  Operating room use of hypertonic solutions: a clinical review.

Authors:  Gustavo Azoubel; Bartolomeu Nascimento; Mauricio Ferri; Sandro Rizoli
Journal:  Clinics (Sao Paulo)       Date:  2008-12       Impact factor: 2.365

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.